Executive vice president, head of global research and development
Merck Serono
Dr. Annalisa Jenkins is global head of R&D at Merck Serono, the biopharmaceutical division of Merck, Darmstadt Germany. Dr. Jenkins was recruited into the company as the global head of development and medical in 2011 by Stefan Oschmann, who was CEO at the time and is now a member of the Merck Executive Board.
After earning her MD, Dr Jenkins began her career as a Royal Naval Physician rising to the rank of Surgeon Lieutenant Commander and serving as the first female physician on the front-line during combat. She started a family while still in the Navy, and then left the service to enter the biopharma industry in 1997, joining Bristol-Myers Squibb.
Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week
Newsletter Signup
The Economist Group is a global organisation and operates a strict privacy policy around the world. Please see our privacy policy here
Join our Opinion Leaders Panel
Complete the form to join our panel and receive rewards every time you complete our business surveys. You will also receive the weekly newsletter, containing the latest cutting edge reports, blogs and industry data.
The Economist Intelligence Unit is part of the Economist Group. The Economist Group is a global organisation and operates a strict privacy policy around the world. To read more about us and our privacy policy please go to http://www.economistgroup.com/privacy